Literature DB >> 19073347

Serum levels of pigment epithelium-derived factor (PEDF) are an independent determinant of insulin resistance in patients with essential hypertension.

Kazuo Nakamura, Sho-ichi Yamagishi, Hisashi Adachi, Takanori Matsui, Yayoi Kurita, Tsutomu Imaizumi.   

Abstract

We have previously found that serum level of pigment epithelium-derived factor (PEDF) is increased in proportion to the accumulation of the number of components of metabolic syndrome in general population. However, the link between PEDF and insulin resistance in hypertensive patients remains unclear. We investigated here whether serum PEDF level was associated with insulin resistance in hypertensive patients. Ninety-seven consecutive outpatients with essential hypertension underwent a complete history and physical examination, determination of blood chemistries, including serum PEDF. In multiple regression analyses, BMI, age (inversely) and PEDF were independently correlated with homeostasis model assessment of insulin resistance (HOMA-IR). When age- and sex-adjusted PEDF levels were stratified by HOMA-IR tertiles, a linear and significant trend was observed. These results demonstrated that serum level of PEDF was an independent determinant of HOMA-IR in patients with essential hypertension. PEDF may play a role in insulin resistance in hypertensive patients. Copyright (c) 2008 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073347     DOI: 10.1016/j.ijcard.2008.11.169

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients.

Authors:  Alicia J Jenkins; Dongxu Fu; Madona Azar; Julie A Stoner; Derrick G Kaufman; Sarah Zhang; Richard L Klein; Maria F Lopes-Virella; Jian-Xing Ma; Timothy J Lyons
Journal:  J Diabetes Complications       Date:  2014-01-17       Impact factor: 2.852

2.  Effect of a 12-month exercise intervention on serum biomarkers of angiogenesis in postmenopausal women: a randomized controlled trial.

Authors:  Catherine Duggan; Liren Xiao; Ching-Yun Wang; Anne McTiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-05       Impact factor: 4.254

3.  Pigment epithelium-derived factor (PEDF) varies with body composition and insulin resistance in healthy young people.

Authors:  Kyle L Sunderland; Jeanie B Tryggestad; Joshua J Wang; April M Teague; Lauren V Pratt; Sarah X Zhang; David M Thompson; Kevin R Short
Journal:  J Clin Endocrinol Metab       Date:  2012-08-28       Impact factor: 5.958

4.  Elevated plasma pigment epithelium-derived factor in children with type 2 diabetes mellitus is attributable to obesity.

Authors:  Jeanie B Tryggestad; Joshua J Wang; Sarah X Zhang; David M Thompson; Kevin R Short
Journal:  Pediatr Diabetes       Date:  2014-10-08       Impact factor: 4.866

5.  Pigment epithelium-derived factor inhibits lysosomal degradation of Bcl-xL and apoptosis in HepG2 cells.

Authors:  Takumi Kawaguchi; Sho-Ichi Yamagishi; Minoru Itou; Koji Okuda; Shuji Sumie; Ryoko Kuromatsu; Masahiro Sakata; Mitsuhiko Abe; Eitaro Taniguchi; Hironori Koga; Masaru Harada; Takato Ueno; Michio Sata
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

6.  Common genetic variation in the SERPINF1 locus determines overall adiposity, obesity-related insulin resistance, and circulating leptin levels.

Authors:  Anja Böhm; Anna-Maria Ordelheide; Jürgen Machann; Martin Heni; Caroline Ketterer; Fausto Machicao; Fritz Schick; Norbert Stefan; Andreas Fritsche; Hans-Ulrich Häring; Harald Staiger
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

7.  Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury.

Authors:  Alaa S Awad; Hanning You; Ting Gao; Anzor Gvritishvili; Timothy K Cooper; Joyce Tombran-Tink
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

8.  PEDF, a pleiotropic WTC-LI biomarker: Machine learning biomarker identification and validation.

Authors:  George Crowley; James Kim; Sophia Kwon; Rachel Lam; David J Prezant; Mengling Liu; Anna Nolan
Journal:  PLoS Comput Biol       Date:  2021-07-21       Impact factor: 4.475

9.  Metformin inhibits expression and secretion of PEDF in adipocyte and hepatocyte via promoting AMPK phosphorylation.

Authors:  Shumin Yang; Qiong Lv; Ting Luo; Lulu Liu; Rufei Gao; Shumei Chen; Peng Ye; Qingfeng Cheng; Qifu Li
Journal:  Mediators Inflamm       Date:  2013-10-31       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.